Issue of Equity
Eco Animal Health Group Plc
ECO Animal Health Group plc
(“Eco†or the “Companyâ€)(“Eco†or the “Companyâ€)
15 December 2010
Application has been made to the London Stock Exchange for 90,000 Ordinary shares in the Company to be admitted to trading on AIM as a result of the exercise of options. It is anticipated that these shares will be admitted to trading on 21 December 2010.
The total number of voting Ordinary shares in issue following this exercise of options will be 52,195,172.
Enquiries
Eco Animal Health Group plcEco Animal Health Group plc
Peter Lawrence,
Executive Chairman                 020 8336 6190
Peter Lawrence,
Executive Chairman                 020 8336 6190
Spiro Financial | Â | Â | Â | Â | Â | ||
Anthony Spiro | 020 8336 6196 | ||||||
 | |||||||
 | |||||||
Cenkos Securities plc (Nominated adviser) | |||||||
Stephen Keys | 020 7397 8926 | ||||||
Elizabeth Bowman | 020 7397 8928 | ||||||
 |
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.